Beacon Pointe Advisors, LLC Gilead Sciences, Inc. Transaction History

Beacon Pointe Advisors, LLC

$8.35 Billion
Q2 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 52,354 shares of GILD stock, worth $4.38 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

52,354

Previous 54,124 3.27%

Holding current value

$4.38 Million

Previous $3.96 Million 9.38%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $111,775 - $128,997	-1,770 Reduced 3.27%	52,354 $3.59 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $622,459 - $759,073	-8,696 Reduced 13.84%	54,124 $3.96 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $85,286 - $96,716	-1,164 Reduced 1.82%	62,820 $5.09 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $1.81 Million - $1.97 Million	24,477 Added 61.96%	63,984 $4.79 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $1.05 Million - $1.19 Million	-13,752 Reduced 25.82%	39,507 $3.04 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $871,051 - $992,397	11,267 Added 26.83%	53,259 $4.42 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $432,999 - $621,637	6,948 Added 19.83%	41,992 $3.61 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $110,982 - $126,770	1,864 Added 5.62%	35,044 $2.16 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $1.72 Million - $1.94 Million	-29,884 Reduced 47.39%	33,180 $2.05 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $1.68 Million - $2.1 Million	28,991 Added 85.08%	63,064 $3.75 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $329,006 - $373,428	5,071 Added 17.49%	34,073 $2.47 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $311,509 - $336,084	4,602 Added 18.86%	29,002 $2.03 Million
Q2 2021 Aug 17, 2021	BUY	$63.47 - $69.35 $1.32 Million - $1.45 Million	20,864 Added 590.05%	24,400 $1.68 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $61,200 - $69,829	-1,020 Reduced 22.39%	3,536 $228,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $258,097 - $294,089	4,556 New	4,556 $265,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $288,206 - $362,369	-4,641 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $335,729 - $389,844	4,641 New	4,641 $356,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Gilead Sciences, Inc. Transaction History